Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Diabetes and weight-loss trials have shown that the GLP-1 drugs target hormones in the gut and the brain that control appetite and feelings of fullness, cutting down on what's described as food noise, or intrusive thoughts of food
Although Semaglutide is very effective at triggering weight loss, it is possible for a poor diet to slow down those results
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist containing Semaglutide, while Mounjaro is a dual GIP and GLP-1 receptor agonist containing Tirzepatide
This timeline is consistent with a possible drug-related effect, though a case report alone cannot establish causation
Solid for many
So, calling it the fat shot doesnt surprise me
